Overview

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Status:
Completed
Trial end date:
2008-07-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether GSK232802 is safe and effective in reducing the frequency and severity of hot flashes associated with menopause.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Estrogens, Conjugated (USP)